[Federal Register Volume 69, Number 136 (Friday, July 16, 2004)]
[Notices]
[Pages 42752-42753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-16112]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Channels and Kidney
Function.
Date: July 12, 2004.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Michele L. Barnard, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-8898, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Translational Research
for the Prevention and Control of Diabetes.
Date: July 23, 2004.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Michele L. Barnard, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-8898, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Primary Biliary
Cirrhosis Clinical Trial.
Date: July 27, 2004.
Time: 3:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: John F. Connaughton, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 757, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-7797, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Therapy in New Onset
Type 1 Diabetes Mellitus.
Date: July 29, 2004.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
[[Page 42753]]
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20814.
Contact Person: Michele L. Barnard, Ph.D., Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-8898, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Develop New Therapies
for Type 1 Diabetes and Its Complications.
Date: July 30, 2004.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard by Marriott, Crystal City, 2899 Jefferson Davis
Highway, Arlington, VA 22202.
Contact Person: Maxine A. Lesniak, MPH Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-7792, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Training for a New
Interdisciplinary Research Workforce.
Date: August 2-3, 2004.
Time: 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Pooks Hill, 5151 Pooks Hill Road,
Bethesda, MD 20814.
Contact Person: Ned Feder, MD, Scientific Review Administrator,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 748,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8890,
[email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Genetic Studies of
Obesity Related in Model Organisms.
Date: August 10, 2004.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Crystal City, 2799 Jefferson Davis Hwy.,
Arlington, VA 22202.
Contact Person: Maxine A. Lesniak, MPH, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-7792, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: July 8, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-16112 Filed 7-15-04; 8:45 am]
BILLING CODE 4140-01-M